                         SEQUENCE LISTING

<110>  Pfizer Inc.
 
<120>  Nanoparticles

<130>  PC72232A

<150>  62/204,659
<151>  2015-08-13

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  429
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1
atgggatgga gctgtatcat cctcttcttg gtagcaacag ctacaggcgt gcactccgag       60

gtgaagctgt tggaatctgg aggaggtttg gtacagccgg ggggttctct gagactctcc      120

tgtgcagctt ctggattcac cttcaatgat ttctacatga actggatccg ccagcctcca      180

gggcaggcac ctgagtggtt gggtgttatt agaaacaaag gtaatggtta cacaacagag      240

gtcaatacat ctgtgaaggg gcggttcacc atctccagag ataataccca aaacatcctc      300

tatcttcaaa tgaacagcct gagagctgag gacaccgcca tttactactg tgcaagaggc      360

ggtccttatt actacagtgg tgacgacgcc ccttactggg gccaaggagt catggtcaca      420

gtctcctca                                                              429


<210>  2
<211>  143
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2

Met Gly Trp Ser Cys Ile Ile Leu Phe Leu Val Ala Thr Ala Thr Gly 
1               5                   10                  15      


Val His Ser Glu Val Lys Leu Leu Glu Ser Gly Gly Gly Leu Val Gln 
            20                  25                  30          


Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe 
        35                  40                  45              


Asn Asp Phe Tyr Met Asn Trp Ile Arg Gln Pro Pro Gly Gln Ala Pro 
    50                  55                  60                  


Glu Trp Leu Gly Val Ile Arg Asn Lys Gly Asn Gly Tyr Thr Thr Glu 
65                  70                  75                  80  


Val Asn Thr Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Thr 
                85                  90                  95      


Gln Asn Ile Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr 
            100                 105                 110         


Ala Ile Tyr Tyr Cys Ala Arg Gly Gly Pro Tyr Tyr Tyr Ser Gly Asp 
        115                 120                 125             


Asp Ala Pro Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser Ser 
    130                 135                 140             


<210>  3
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3

Met Gly Trp Ser Cys Ile Ile Leu Phe Leu Val Ala Thr Ala Thr Gly 
1               5                   10                  15      


Val His Ser 
            


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4

Gly Phe Thr Phe Asn Asp Phe Tyr Met Asn 
1               5                   10  


<210>  5
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  5

Val Ile Arg Asn Lys Gly Asn Gly Tyr Thr Thr Glu Val Asn Thr Ser 
1               5                   10                  15      


Val Lys Gly 
            


<210>  6
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  6

Gly Gly Pro Tyr Tyr Tyr Ser Gly Asp Asp Ala Pro Tyr 
1               5                   10              


<210>  7
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  7
atgggatgga gctgtatcat cctcttcttg gtagcaacag ctacaggcgt gcactccgac       60

atccagatga cccagtctcc atcctccctg tctgcatctg taggagacag agtcaccatc      120

acttgccatg ccagtcagaa catcaagggt tggttagcct ggtatcagca gaaaccaggg      180

aaagccccta agctcctgat ctataaggca tctagcctgc aatcaggggt cccatcaagg      240

ttcagtggca gtggatctgg gacagatttc actctcacca tcagcagtct gcaacctgaa      300

gattttgcaa cttactactg tcagcattat caaagctttc cgtggacctt cggtcaaggc      360

accaaggtgg aaatcaaa                                                    378


<210>  8
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  8

Met Gly Trp Ser Cys Ile Ile Leu Phe Leu Val Ala Thr Ala Thr Gly 
1               5                   10                  15      


Val His Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala 
            20                  25                  30          


Ser Val Gly Asp Arg Val Thr Ile Thr Cys His Ala Ser Gln Asn Ile 
        35                  40                  45              


Lys Gly Trp Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys 
    50                  55                  60                  


Leu Leu Ile Tyr Lys Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
65                  70                  75                  80  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
                85                  90                  95      


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln His Tyr Gln Ser 
            100                 105                 110         


Phe Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
        115                 120                 125     


<210>  9
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  9

Met Gly Trp Ser Cys Ile Ile Leu Phe Leu Val Ala Thr Ala Thr Gly 
1               5                   10                  15      


Val His Ser 
            


<210>  10
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  10

His Ala Ser Gln Asn Ile Lys Gly Trp Leu Ala 
1               5                   10      


<210>  11
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  11

Lys Ala Ser Ser Leu Gln Ser 
1               5           


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  12

Gln His Tyr Gln Ser Phe Pro Trp Thr 
1               5                   


<210>  13
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  13

Glu Val Lys Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asp Phe 
            20                  25                  30          


Tyr Met Asn Trp Ile Arg Gln Pro Pro Gly Gln Ala Pro Glu Trp Leu 
        35                  40                  45              


Gly Val Ile Arg Asn Lys Gly Asn Gly Tyr Thr Thr Glu Val Asn Thr 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Thr Gln Asn Ile 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr 
                85                  90                  95      


Tyr Cys Ala Arg Gly Gly Pro Tyr Tyr Tyr Ser Gly Asp Asp Ala Pro 
            100                 105                 110         


Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser Ser 
        115                 120                 


<210>  14
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  14

Trp Gly Gln Gly Val Met Val Thr Val Ser Ser 
1               5                   10      


<210>  15
<211>  98
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  15

Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys 
1               5                   10                  15      


Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr 
            20                  25                  30          


Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser 
        35                  40                  45              


Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr 
65                  70                  75                  80  


Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys 
                85                  90                  95      


Lys Val 
        


<210>  16
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  16

Glu Pro Lys Ser Cys Asp Lys Thr His Thr Gly Pro Pro Pro Cys 
1               5                   10                  15  


